1. Home
  2. HUN vs GH Comparison

HUN vs GH Comparison

Compare HUN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$14.23

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$126.47

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
GH
Founded
1970
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
12.7B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
HUN
GH
Price
$14.23
$126.47
Analyst Decision
Hold
Strong Buy
Analyst Count
11
19
Target Price
$12.09
$119.79
AVG Volume (30 Days)
4.1M
2.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.64%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
$5,683,000,000.00
$982,021,000.00
Revenue This Year
$3.08
$33.30
Revenue Next Year
$5.27
$28.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.88
52 Week Low
$7.30
$40.36
52 Week High
$15.90
$134.28

Technical Indicators

Market Signals
Indicator
HUN
GH
Relative Strength Index (RSI) 47.17 63.89
Support Level $13.13 $94.02
Resistance Level $14.25 N/A
Average True Range (ATR) 0.61 7.02
MACD -0.07 0.88
Stochastic Oscillator 41.85 78.41

Price Performance

Historical Comparison
HUN
GH

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: